APA (7th ed.) Citation

AM, T., ML, M., P, P., F, P., S, T., MS, D. P., . . . G, G. (2022). Severe rituximab-induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura. Pediatric blood & cancer, 69(2), e29375. https://doi.org/10.1002/pbc.29375

Chicago Style (17th ed.) Citation

AM, Testi, Moleti ML, Papoff P, Paoletti F, Trisolini S, De Propris MS, Bianchi S, Kaiser F, and Gentile G. "Severe Rituximab-induced Pneumonitis in an Immunocompromised Child with Acquired Thrombotic Thrombocytopenic Purpura." Pediatric Blood & Cancer 69, no. 2 (2022): e29375. https://doi.org/10.1002/pbc.29375.

MLA (9th ed.) Citation

AM, Testi, et al. "Severe Rituximab-induced Pneumonitis in an Immunocompromised Child with Acquired Thrombotic Thrombocytopenic Purpura." Pediatric Blood & Cancer, vol. 69, no. 2, 2022, p. e29375, https://doi.org/10.1002/pbc.29375.